- SEK965.73m
- SEK836.63m
- SEK441.90m
Brief: C-Rad And Elekta Expand Sales And Distribution Agreement To Include China
Brief: C Rad Q2 Order Intake Down At SEK 62.3 Mln
Brief: C-RAD Gets Order Worth Around SEK 11 Mln
Brief: C-RAD Signs LoI with Belgium Company Ion Beam Applications
Brief: C-RAD Says Former Employee Files Lawsuit For Compensation
Brief: C-Rad AB - Q1 Order Intake Amounted To SEK 47.7 mln
Brief: C-RAD Prepares For Period Of Lower Demand Due To COVID-19
Brief: C-Rad Carries Out Directed New Share Issue Of 2,500,000 Series B Shares, Raising Proceeds Of About SEK 108 Mln
Brief: C-Rad Q4 Operating Result Swings To Loss Of SEK 12.1 Million
Brief: C-Rad: Leave To Appeal Granted In Patent Dispute
Brief: C-Rad Appoints Henrik Bergentoft New CFO
Brief: C-RAD gets penalty imposed by Disciplinary Committee at Nasdaq Stockholm
Brief: C-Rad Q3 Operating Profit At SEK 1.7 Million
Brief: C-Rad Q2 Total Order Intake Up At SEK 64.1 Mln
Brief: C-RAD And Mevion Release Integration For Improved Treatment Quality In Proton Therapy
Brief: Court Confirms C-RAD's Entitlement To Patent Application
Brief: C-Rad Gets Order From MVZ Prof. Dr. Uhlenbrock and Partner In Germany
Swedish stocks: seen opening higher, SEB Q2 profit beats expectations
Brief: C-Rad And Elekta Sign Distribution Deal For North American And Mexican Market